NFkappaB inhibitors (ReveraGen BioPharma)

N/A

Report date: 2025/03/20 16:07:07
NME

Base Information

Drug NameNFkappaB inhibitors (ReveraGen BioPharma)
Drug Alias Namenon-hormonal steroids (Validus Biopharma)VBP series (ReveraGen)VBP series (Validus Biopharma)
ClassificationSmall molecules > Steroids
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReveragen Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReveragen Biopharma Inc
Active IndicationsN/A
Inactive IndicationsAsthmaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A